ADVERUM BIOTECHNOLOGIES, INC. has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan AVALANCHE BIOTECHNOLOGIES 401(K) PLAN
| Measure | Date | Value |
|---|
| 2023 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2023 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2023-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total transfer of assets to this plan | 2023-12-31 | $0 |
| Total transfer of assets from this plan | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Expenses. Interest paid | 2023-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $8,123,021 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $1,832,450 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $1,795,449 |
| Expenses. Certain deemed distributions of participant loans | 2023-12-31 | $0 |
| Value of total corrective distributions | 2023-12-31 | $4,645 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $5,061,990 |
| Value of total assets at end of year | 2023-12-31 | $20,668,380 |
| Value of total assets at beginning of year | 2023-12-31 | $14,377,809 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $32,356 |
| Total income from rents | 2023-12-31 | $0 |
| Total interest from all sources | 2023-12-31 | $19,829 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $698,188 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $698,188 |
| Assets. Real estate other than employer real property at end of year | 2023-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2023-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $2,051,566 |
| Participant contributions at end of year | 2023-12-31 | $141,814 |
| Participant contributions at beginning of year | 2023-12-31 | $139,760 |
| Participant contributions at end of year | 2023-12-31 | $0 |
| Participant contributions at beginning of year | 2023-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2023-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $2,136,229 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2023-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2023-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2023-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-12-31 | $0 |
| Other income not declared elsewhere | 2023-12-31 | $0 |
| Administrative expenses (other) incurred | 2023-12-31 | $0 |
| Liabilities. Value of operating payables at end of year | 2023-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2023-12-31 | $0 |
| Total non interest bearing cash at end of year | 2023-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2023-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Income. Non cash contributions | 2023-12-31 | $0 |
| Value of net income/loss | 2023-12-31 | $6,290,571 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $20,668,380 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $14,377,809 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2023-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2023-12-31 | $0 |
| Investment advisory and management fees | 2023-12-31 | $11,341 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $20,161,147 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $13,708,244 |
| Value of interest in pooled separate accounts at end of year | 2023-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2023-12-31 | $0 |
| Interest on participant loans | 2023-12-31 | $9,557 |
| Income. Interest from loans (other than to participants) | 2023-12-31 | $0 |
| Interest earned on other investments | 2023-12-31 | $0 |
| Income. Interest from US Government securities | 2023-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2023-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2023-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2023-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2023-12-31 | $132,736 |
| Value of interest in common/collective trusts at beginning of year | 2023-12-31 | $161,620 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-12-31 | $232,683 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2023-12-31 | $368,185 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2023-12-31 | $368,185 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-12-31 | $10,272 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2023-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2023-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2023-12-31 | $0 |
| Asset value of US Government securities at end of year | 2023-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2023-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $2,337,204 |
| Net investment gain/loss from pooled separate accounts | 2023-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2023-12-31 | $5,810 |
| Net gain/loss from 103.12 investment entities | 2023-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Assets. Invements in employer securities at end of year | 2023-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2023-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2023-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2023-12-31 | $0 |
| Contributions received in cash from employer | 2023-12-31 | $874,195 |
| Employer contributions (assets) at end of year | 2023-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2023-12-31 | $0 |
| Income. Dividends from preferred stock | 2023-12-31 | $0 |
| Income. Dividends from common stock | 2023-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $1,795,449 |
| Asset. Corporate debt instrument preferred debt at end of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2023-12-31 | $0 |
| Contract administrator fees | 2023-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2023-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2023-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2023-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2023-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2023-12-31 | $0 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Aggregate proceeds on sale of assets | 2023-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2023-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2023-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2023-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2023-12-31 | 300840934 |
| Unrealized appreciation/depreciation of real estate assets | 2023-01-01 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-01-01 | $0 |
| Total unrealized appreciation/depreciation of assets | 2023-01-01 | $0 |
| Total transfer of assets to this plan | 2023-01-01 | $0 |
| Total transfer of assets from this plan | 2023-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total income from all sources (including contributions) | 2023-01-01 | $8,123,021 |
| Total loss/gain on sale of assets | 2023-01-01 | $0 |
| Total of all expenses incurred | 2023-01-01 | $1,832,450 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-01-01 | $1,795,449 |
| Expenses. Certain deemed distributions of participant loans | 2023-01-01 | $0 |
| Value of total corrective distributions | 2023-01-01 | $4,645 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-01-01 | $5,061,990 |
| Value of total assets at end of year | 2023-01-01 | $20,668,380 |
| Value of total assets at beginning of year | 2023-01-01 | $14,377,809 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-01-01 | $32,356 |
| Total income from rents | 2023-01-01 | $0 |
| Total interest from all sources | 2023-01-01 | $19,829 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-01-01 | $698,188 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-01-01 | $698,188 |
| Assets. Real estate other than employer real property at end of year | 2023-01-01 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2023-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-01-01 | $0 |
| Was this plan covered by a fidelity bond | 2023-01-01 | Yes |
| Value of fidelity bond cover | 2023-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-01-01 | No |
| Contributions received from participants | 2023-01-01 | $2,051,566 |
| Participant contributions at end of year | 2023-01-01 | $141,814 |
| Participant contributions at beginning of year | 2023-01-01 | $139,760 |
| Participant contributions at end of year | 2023-01-01 | $0 |
| Participant contributions at beginning of year | 2023-01-01 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2023-01-01 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-01-01 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-01-01 | $2,136,229 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2023-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-01-01 | $0 |
| Assets. Loans (other than to participants) at end of year | 2023-01-01 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2023-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-01-01 | $0 |
| Other income not declared elsewhere | 2023-01-01 | $0 |
| Administrative expenses (other) incurred | 2023-01-01 | $0 |
| Liabilities. Value of operating payables at end of year | 2023-01-01 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2023-01-01 | $0 |
| Total non interest bearing cash at end of year | 2023-01-01 | $0 |
| Total non interest bearing cash at beginning of year | 2023-01-01 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Income. Non cash contributions | 2023-01-01 | $0 |
| Value of net income/loss | 2023-01-01 | $6,290,571 |
| Value of net assets at end of year (total assets less liabilities) | 2023-01-01 | $20,668,380 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-01-01 | $14,377,809 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-01-01 | No |
| Assets. partnership/joint venture interests at end of year | 2023-01-01 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2023-01-01 | $0 |
| Investment advisory and management fees | 2023-01-01 | $11,341 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-01-01 | $20,161,147 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-01-01 | $13,708,244 |
| Value of interest in pooled separate accounts at end of year | 2023-01-01 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2023-01-01 | $0 |
| Interest on participant loans | 2023-01-01 | $9,557 |
| Income. Interest from loans (other than to participants) | 2023-01-01 | $0 |
| Interest earned on other investments | 2023-01-01 | $0 |
| Income. Interest from US Government securities | 2023-01-01 | $0 |
| Income. Interest from corporate debt instruments | 2023-01-01 | $0 |
| Value of interest in master investment trust accounts at end of year | 2023-01-01 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2023-01-01 | $0 |
| Value of interest in common/collective trusts at end of year | 2023-01-01 | $132,736 |
| Value of interest in common/collective trusts at beginning of year | 2023-01-01 | $161,620 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-01-01 | $232,683 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-01-01 | $10,272 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2023-01-01 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2023-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-01-01 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2023-01-01 | $0 |
| Asset value of US Government securities at end of year | 2023-01-01 | $0 |
| Asset value of US Government securities at beginning of year | 2023-01-01 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-01-01 | $2,337,204 |
| Net investment gain/loss from pooled separate accounts | 2023-01-01 | $0 |
| Net investment gain or loss from common/collective trusts | 2023-01-01 | $5,810 |
| Net gain/loss from 103.12 investment entities | 2023-01-01 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-01-01 | No |
| Assets. Invements in employer securities at end of year | 2023-01-01 | $0 |
| Assets. Invements in employer securities at beginning of year | 2023-01-01 | $0 |
| Assets. Value of employer real property at end of year | 2023-01-01 | $0 |
| Assets. Value of employer real property at beginning of year | 2023-01-01 | $0 |
| Contributions received in cash from employer | 2023-01-01 | $874,195 |
| Employer contributions (assets) at end of year | 2023-01-01 | $0 |
| Employer contributions (assets) at beginning of year | 2023-01-01 | $0 |
| Income. Dividends from preferred stock | 2023-01-01 | $0 |
| Income. Dividends from common stock | 2023-01-01 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-01-01 | $1,795,449 |
| Asset. Corporate debt instrument preferred debt at end of year | 2023-01-01 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2023-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2023-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2023-01-01 | $0 |
| Contract administrator fees | 2023-01-01 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2023-01-01 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-01-01 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-01-01 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2023-01-01 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2023-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2023-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2023-01-01 | $0 |
| Did the plan have assets held for investment | 2023-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-01-01 | No |
| Aggregate proceeds on sale of assets | 2023-01-01 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2023-01-01 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2023-01-01 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2023-01-01 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2023-01-01 | 1 |
| Accountancy firm name | 2023-01-01 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2023-01-01 | 300840934 |
| 2022 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2022-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total transfer of assets to this plan | 2022-12-31 | $0 |
| Total transfer of assets from this plan | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Expenses. Interest paid | 2022-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $2,058,370 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $1,247,039 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $1,219,040 |
| Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $0 |
| Value of total corrective distributions | 2022-12-31 | $3,162 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $4,569,325 |
| Value of total assets at end of year | 2022-12-31 | $14,377,809 |
| Value of total assets at beginning of year | 2022-12-31 | $13,566,478 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $24,837 |
| Total income from rents | 2022-12-31 | $0 |
| Total interest from all sources | 2022-12-31 | $12,874 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $866,307 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $866,307 |
| Assets. Real estate other than employer real property at end of year | 2022-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2022-12-31 | $0 |
| Administrative expenses professional fees incurred | 2022-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $2,786,967 |
| Participant contributions at end of year | 2022-12-31 | $139,760 |
| Participant contributions at beginning of year | 2022-12-31 | $107,723 |
| Participant contributions at end of year | 2022-12-31 | $0 |
| Participant contributions at beginning of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2022-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $628,749 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2022-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $0 |
| Other income not declared elsewhere | 2022-12-31 | $0 |
| Administrative expenses (other) incurred | 2022-12-31 | $17,645 |
| Liabilities. Value of operating payables at end of year | 2022-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2022-12-31 | $0 |
| Total non interest bearing cash at end of year | 2022-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2022-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Income. Non cash contributions | 2022-12-31 | $0 |
| Value of net income/loss | 2022-12-31 | $811,331 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $14,377,809 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $13,566,478 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2022-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2022-12-31 | $0 |
| Investment advisory and management fees | 2022-12-31 | $7,192 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $13,708,244 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $13,023,384 |
| Value of interest in pooled separate accounts at end of year | 2022-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $0 |
| Interest on participant loans | 2022-12-31 | $6,342 |
| Income. Interest from loans (other than to participants) | 2022-12-31 | $0 |
| Interest earned on other investments | 2022-12-31 | $0 |
| Income. Interest from US Government securities | 2022-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2022-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2022-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2022-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $161,620 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $83,638 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $368,185 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $351,733 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $351,733 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $6,532 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2022-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2022-12-31 | $0 |
| Asset value of US Government securities at end of year | 2022-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2022-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-3,379,045 |
| Net investment gain/loss from pooled separate accounts | 2022-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $-11,091 |
| Net gain/loss from 103.12 investment entities | 2022-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Assets. Invements in employer securities at end of year | 2022-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2022-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2022-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2022-12-31 | $0 |
| Contributions received in cash from employer | 2022-12-31 | $1,153,609 |
| Employer contributions (assets) at end of year | 2022-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2022-12-31 | $0 |
| Income. Dividends from preferred stock | 2022-12-31 | $0 |
| Income. Dividends from common stock | 2022-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $1,219,040 |
| Asset. Corporate debt instrument preferred debt at end of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $0 |
| Contract administrator fees | 2022-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2022-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2022-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2022-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2022-12-31 | $0 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Aggregate proceeds on sale of assets | 2022-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2022-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2022-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2022-12-31 | 300840934 |
| Unrealized appreciation/depreciation of real estate assets | 2022-01-01 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-01-01 | $0 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $0 |
| Total transfer of assets to this plan | 2022-01-01 | $0 |
| Total transfer of assets from this plan | 2022-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total income from all sources (including contributions) | 2022-01-01 | $2,058,370 |
| Total loss/gain on sale of assets | 2022-01-01 | $0 |
| Total of all expenses incurred | 2022-01-01 | $1,247,039 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-01-01 | $1,219,040 |
| Expenses. Certain deemed distributions of participant loans | 2022-01-01 | $0 |
| Value of total corrective distributions | 2022-01-01 | $3,162 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-01-01 | $4,569,325 |
| Value of total assets at end of year | 2022-01-01 | $14,377,809 |
| Value of total assets at beginning of year | 2022-01-01 | $13,566,478 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $24,837 |
| Total income from rents | 2022-01-01 | $0 |
| Total interest from all sources | 2022-01-01 | $12,874 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $866,307 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-01-01 | $866,307 |
| Assets. Real estate other than employer real property at end of year | 2022-01-01 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2022-01-01 | $0 |
| Administrative expenses professional fees incurred | 2022-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-01-01 | $0 |
| Was this plan covered by a fidelity bond | 2022-01-01 | Yes |
| Value of fidelity bond cover | 2022-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-01-01 | No |
| Contributions received from participants | 2022-01-01 | $2,786,967 |
| Participant contributions at end of year | 2022-01-01 | $139,760 |
| Participant contributions at beginning of year | 2022-01-01 | $107,723 |
| Participant contributions at end of year | 2022-01-01 | $0 |
| Participant contributions at beginning of year | 2022-01-01 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2022-01-01 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2022-01-01 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-01-01 | $628,749 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-01-01 | $0 |
| Assets. Loans (other than to participants) at end of year | 2022-01-01 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2022-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-01-01 | $0 |
| Other income not declared elsewhere | 2022-01-01 | $0 |
| Administrative expenses (other) incurred | 2022-01-01 | $17,645 |
| Liabilities. Value of operating payables at end of year | 2022-01-01 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2022-01-01 | $0 |
| Total non interest bearing cash at end of year | 2022-01-01 | $0 |
| Total non interest bearing cash at beginning of year | 2022-01-01 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Income. Non cash contributions | 2022-01-01 | $0 |
| Value of net income/loss | 2022-01-01 | $811,331 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $14,377,809 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $13,566,478 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-01-01 | No |
| Assets. partnership/joint venture interests at end of year | 2022-01-01 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2022-01-01 | $0 |
| Investment advisory and management fees | 2022-01-01 | $7,192 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-01-01 | $13,708,244 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-01-01 | $13,023,384 |
| Value of interest in pooled separate accounts at end of year | 2022-01-01 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2022-01-01 | $0 |
| Interest on participant loans | 2022-01-01 | $6,342 |
| Income. Interest from loans (other than to participants) | 2022-01-01 | $0 |
| Interest earned on other investments | 2022-01-01 | $0 |
| Income. Interest from US Government securities | 2022-01-01 | $0 |
| Income. Interest from corporate debt instruments | 2022-01-01 | $0 |
| Value of interest in master investment trust accounts at end of year | 2022-01-01 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2022-01-01 | $0 |
| Value of interest in common/collective trusts at end of year | 2022-01-01 | $161,620 |
| Value of interest in common/collective trusts at beginning of year | 2022-01-01 | $83,638 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-01-01 | $368,185 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-01-01 | $6,532 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2022-01-01 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-01-01 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2022-01-01 | $0 |
| Asset value of US Government securities at end of year | 2022-01-01 | $0 |
| Asset value of US Government securities at beginning of year | 2022-01-01 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-01-01 | $-3,379,045 |
| Net investment gain/loss from pooled separate accounts | 2022-01-01 | $0 |
| Net investment gain or loss from common/collective trusts | 2022-01-01 | $-11,091 |
| Net gain/loss from 103.12 investment entities | 2022-01-01 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-01-01 | No |
| Assets. Invements in employer securities at end of year | 2022-01-01 | $0 |
| Assets. Invements in employer securities at beginning of year | 2022-01-01 | $0 |
| Assets. Value of employer real property at end of year | 2022-01-01 | $0 |
| Assets. Value of employer real property at beginning of year | 2022-01-01 | $0 |
| Contributions received in cash from employer | 2022-01-01 | $1,153,609 |
| Employer contributions (assets) at end of year | 2022-01-01 | $0 |
| Employer contributions (assets) at beginning of year | 2022-01-01 | $0 |
| Income. Dividends from preferred stock | 2022-01-01 | $0 |
| Income. Dividends from common stock | 2022-01-01 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-01-01 | $1,219,040 |
| Asset. Corporate debt instrument preferred debt at end of year | 2022-01-01 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2022-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-01-01 | $0 |
| Contract administrator fees | 2022-01-01 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-01-01 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-01-01 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-01-01 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2022-01-01 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2022-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2022-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2022-01-01 | $0 |
| Did the plan have assets held for investment | 2022-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-01-01 | No |
| Aggregate proceeds on sale of assets | 2022-01-01 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2022-01-01 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2022-01-01 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2022-01-01 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2022-01-01 | 1 |
| Accountancy firm name | 2022-01-01 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2022-01-01 | 300840934 |
| 2021 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2021 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2021-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
| Total transfer of assets to this plan | 2021-12-31 | $0 |
| Total transfer of assets from this plan | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Expenses. Interest paid | 2021-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $5,916,373 |
| Total loss/gain on sale of assets | 2021-12-31 | $0 |
| Total of all expenses incurred | 2021-12-31 | $632,225 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $599,423 |
| Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $-1,045 |
| Value of total corrective distributions | 2021-12-31 | $4,478 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $4,285,538 |
| Value of total assets at end of year | 2021-12-31 | $13,566,478 |
| Value of total assets at beginning of year | 2021-12-31 | $8,282,330 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $29,369 |
| Total income from rents | 2021-12-31 | $0 |
| Total interest from all sources | 2021-12-31 | $5,032 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $840,393 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $840,393 |
| Assets. Real estate other than employer real property at end of year | 2021-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2021-12-31 | $0 |
| Administrative expenses professional fees incurred | 2021-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2021-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2021-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
| Value of fidelity bond cover | 2021-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $2,503,710 |
| Participant contributions at end of year | 2021-12-31 | $107,723 |
| Participant contributions at beginning of year | 2021-12-31 | $70,212 |
| Participant contributions at end of year | 2021-12-31 | $0 |
| Participant contributions at beginning of year | 2021-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2021-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2021-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $779,324 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2021-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2021-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2021-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $0 |
| Other income not declared elsewhere | 2021-12-31 | $0 |
| Administrative expenses (other) incurred | 2021-12-31 | $25,096 |
| Liabilities. Value of operating payables at end of year | 2021-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2021-12-31 | $0 |
| Total non interest bearing cash at end of year | 2021-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2021-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Income. Non cash contributions | 2021-12-31 | $0 |
| Value of net income/loss | 2021-12-31 | $5,284,148 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $13,566,478 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $8,282,330 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2021-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2021-12-31 | $0 |
| Investment advisory and management fees | 2021-12-31 | $4,273 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $13,023,384 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $7,798,787 |
| Value of interest in pooled separate accounts at end of year | 2021-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $0 |
| Interest on participant loans | 2021-12-31 | $5,000 |
| Income. Interest from loans (other than to participants) | 2021-12-31 | $0 |
| Interest earned on other investments | 2021-12-31 | $0 |
| Income. Interest from US Government securities | 2021-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2021-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2021-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2021-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2021-12-31 | $83,638 |
| Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $114,085 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $351,733 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $299,246 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $299,246 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $32 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2021-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2021-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2021-12-31 | $0 |
| Asset value of US Government securities at end of year | 2021-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2021-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $787,692 |
| Net investment gain/loss from pooled separate accounts | 2021-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2021-12-31 | $-2,282 |
| Net gain/loss from 103.12 investment entities | 2021-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Assets. Invements in employer securities at end of year | 2021-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2021-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2021-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2021-12-31 | $0 |
| Contributions received in cash from employer | 2021-12-31 | $1,002,504 |
| Employer contributions (assets) at end of year | 2021-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2021-12-31 | $0 |
| Income. Dividends from preferred stock | 2021-12-31 | $0 |
| Income. Dividends from common stock | 2021-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $599,423 |
| Asset. Corporate debt instrument preferred debt at end of year | 2021-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2021-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2021-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2021-12-31 | $0 |
| Contract administrator fees | 2021-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2021-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2021-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2021-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2021-12-31 | $0 |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| Aggregate proceeds on sale of assets | 2021-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2021-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2021-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
| Accountancy firm name | 2021-12-31 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2021-12-31 | 300840934 |
| 2020 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2020-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total transfer of assets to this plan | 2020-12-31 | $0 |
| Total transfer of assets from this plan | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Expenses. Interest paid | 2020-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $3,910,250 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $1,296,887 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $1,274,175 |
| Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $2,326 |
| Value of total corrective distributions | 2020-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $2,838,906 |
| Value of total assets at end of year | 2020-12-31 | $8,282,330 |
| Value of total assets at beginning of year | 2020-12-31 | $5,668,967 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $20,386 |
| Total income from rents | 2020-12-31 | $0 |
| Total interest from all sources | 2020-12-31 | $4,088 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $330,425 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $330,425 |
| Assets. Real estate other than employer real property at end of year | 2020-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2020-12-31 | $0 |
| Administrative expenses professional fees incurred | 2020-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
| Value of fidelity bond cover | 2020-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $1,524,832 |
| Participant contributions at end of year | 2020-12-31 | $70,212 |
| Participant contributions at beginning of year | 2020-12-31 | $33,943 |
| Participant contributions at end of year | 2020-12-31 | $0 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $661,567 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2020-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
| Other income not declared elsewhere | 2020-12-31 | $0 |
| Administrative expenses (other) incurred | 2020-12-31 | $17,850 |
| Liabilities. Value of operating payables at end of year | 2020-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $0 |
| Total non interest bearing cash at end of year | 2020-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Income. Non cash contributions | 2020-12-31 | $0 |
| Value of net income/loss | 2020-12-31 | $2,613,363 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $8,282,330 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $5,668,967 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2020-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $0 |
| Investment advisory and management fees | 2020-12-31 | $2,536 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $7,798,787 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $5,051,213 |
| Value of interest in pooled separate accounts at end of year | 2020-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $0 |
| Interest on participant loans | 2020-12-31 | $2,744 |
| Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
| Interest earned on other investments | 2020-12-31 | $0 |
| Income. Interest from US Government securities | 2020-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2020-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2020-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2020-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $114,085 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $71,894 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $299,246 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $511,917 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $511,917 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $1,344 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2020-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
| Asset value of US Government securities at end of year | 2020-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2020-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $730,116 |
| Net investment gain/loss from pooled separate accounts | 2020-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $6,715 |
| Net gain/loss from 103.12 investment entities | 2020-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Assets. Invements in employer securities at end of year | 2020-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2020-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2020-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2020-12-31 | $0 |
| Contributions received in cash from employer | 2020-12-31 | $652,507 |
| Employer contributions (assets) at end of year | 2020-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
| Income. Dividends from preferred stock | 2020-12-31 | $0 |
| Income. Dividends from common stock | 2020-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $1,274,175 |
| Asset. Corporate debt instrument preferred debt at end of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $0 |
| Contract administrator fees | 2020-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2020-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2020-12-31 | $0 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Aggregate proceeds on sale of assets | 2020-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2020-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
| Accountancy firm name | 2020-12-31 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2020-12-31 | 300840934 |
| 2019 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2019 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2019-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
| Total transfer of assets to this plan | 2019-12-31 | $0 |
| Total transfer of assets from this plan | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Expenses. Interest paid | 2019-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2019-12-31 | $0 |
| Total income from all sources (including contributions) | 2019-12-31 | $2,430,500 |
| Total loss/gain on sale of assets | 2019-12-31 | $0 |
| Total of all expenses incurred | 2019-12-31 | $1,001,999 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $978,978 |
| Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $0 |
| Value of total corrective distributions | 2019-12-31 | $5,509 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $1,469,246 |
| Value of total assets at end of year | 2019-12-31 | $5,668,967 |
| Value of total assets at beginning of year | 2019-12-31 | $4,240,466 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $17,512 |
| Total income from rents | 2019-12-31 | $0 |
| Total interest from all sources | 2019-12-31 | $11,311 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $231,967 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $231,967 |
| Assets. Real estate other than employer real property at end of year | 2019-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2019-12-31 | $0 |
| Administrative expenses professional fees incurred | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Value of fidelity bond cover | 2019-12-31 | $200,000 |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Contributions received from participants | 2019-12-31 | $939,131 |
| Participant contributions at end of year | 2019-12-31 | $33,943 |
| Participant contributions at beginning of year | 2019-12-31 | $41,449 |
| Participant contributions at end of year | 2019-12-31 | $0 |
| Participant contributions at beginning of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $129,429 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $0 |
| Other income not declared elsewhere | 2019-12-31 | $0 |
| Administrative expenses (other) incurred | 2019-12-31 | $14,386 |
| Liabilities. Value of operating payables at end of year | 2019-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $0 |
| Total non interest bearing cash at end of year | 2019-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2019-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Income. Non cash contributions | 2019-12-31 | $0 |
| Value of net income/loss | 2019-12-31 | $1,428,501 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $5,668,967 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $4,240,466 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2019-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $0 |
| Investment advisory and management fees | 2019-12-31 | $3,126 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $5,051,213 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $3,666,172 |
| Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $0 |
| Interest on participant loans | 2019-12-31 | $2,368 |
| Income. Interest from loans (other than to participants) | 2019-12-31 | $0 |
| Interest earned on other investments | 2019-12-31 | $0 |
| Income. Interest from US Government securities | 2019-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $71,894 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $65,384 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $511,917 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $467,461 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $467,461 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $8,943 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2019-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2019-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2019-12-31 | $0 |
| Asset value of US Government securities at end of year | 2019-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2019-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $714,975 |
| Net investment gain/loss from pooled separate accounts | 2019-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $3,001 |
| Net gain/loss from 103.12 investment entities | 2019-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Assets. Invements in employer securities at end of year | 2019-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2019-12-31 | $0 |
| Contributions received in cash from employer | 2019-12-31 | $400,686 |
| Employer contributions (assets) at end of year | 2019-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2019-12-31 | $0 |
| Income. Dividends from preferred stock | 2019-12-31 | $0 |
| Income. Dividends from common stock | 2019-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $978,978 |
| Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $0 |
| Contract administrator fees | 2019-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2019-12-31 | $0 |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Aggregate proceeds on sale of assets | 2019-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Accountancy firm name | 2019-12-31 | PENSION ASSURANCE LLP |
| Accountancy firm EIN | 2019-12-31 | 300840934 |
| 2018 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2018 401k financial data |
|---|
| Transfers to/from the plan | 2018-12-31 | $0 |
| Total plan liabilities at end of year | 2018-12-31 | $0 |
| Total plan liabilities at beginning of year | 2018-12-31 | $0 |
| Total income from all sources | 2018-12-31 | $1,482,607 |
| Expenses. Total of all expenses incurred | 2018-12-31 | $589,522 |
| Benefits paid (including direct rollovers) | 2018-12-31 | $569,001 |
| Total plan assets at end of year | 2018-12-31 | $4,240,466 |
| Total plan assets at beginning of year | 2018-12-31 | $3,347,381 |
| Value of fidelity bond covering the plan | 2018-12-31 | $200,000 |
| Total contributions received or receivable from participants | 2018-12-31 | $923,460 |
| Expenses. Other expenses not covered elsewhere | 2018-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2018-12-31 | $492,728 |
| Other income received | 2018-12-31 | $-344,396 |
| Noncash contributions received | 2018-12-31 | $0 |
| Net income (gross income less expenses) | 2018-12-31 | $893,085 |
| Net plan assets at end of year (total assets less liabilities) | 2018-12-31 | $4,240,466 |
| Net plan assets at beginning of year (total assets less liabilities) | 2018-12-31 | $3,347,381 |
| Assets. Value of participant loans | 2018-12-31 | $41,449 |
| Total contributions received or receivable from employer(s) | 2018-12-31 | $410,815 |
| Value of certain deemed distributions of participant loans | 2018-12-31 | $0 |
| Value of corrective distributions | 2018-12-31 | $7,870 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2018-12-31 | $12,651 |
| 2017 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2017 401k financial data |
|---|
| Transfers to/from the plan | 2017-12-31 | $0 |
| Total plan liabilities at end of year | 2017-12-31 | $0 |
| Total plan liabilities at beginning of year | 2017-12-31 | $0 |
| Total income from all sources | 2017-12-31 | $2,009,829 |
| Expenses. Total of all expenses incurred | 2017-12-31 | $432,167 |
| Benefits paid (including direct rollovers) | 2017-12-31 | $425,726 |
| Total plan assets at end of year | 2017-12-31 | $3,347,381 |
| Total plan assets at beginning of year | 2017-12-31 | $1,769,719 |
| Value of fidelity bond covering the plan | 2017-12-31 | $200,000 |
| Total contributions received or receivable from participants | 2017-12-31 | $724,053 |
| Expenses. Other expenses not covered elsewhere | 2017-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2017-12-31 | $248,339 |
| Other income received | 2017-12-31 | $363,685 |
| Noncash contributions received | 2017-12-31 | $0 |
| Net income (gross income less expenses) | 2017-12-31 | $1,577,662 |
| Net plan assets at end of year (total assets less liabilities) | 2017-12-31 | $3,347,381 |
| Net plan assets at beginning of year (total assets less liabilities) | 2017-12-31 | $1,769,719 |
| Assets. Value of participant loans | 2017-12-31 | $36,513 |
| Total contributions received or receivable from employer(s) | 2017-12-31 | $673,752 |
| Value of certain deemed distributions of participant loans | 2017-12-31 | $0 |
| Value of corrective distributions | 2017-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2017-12-31 | $6,441 |
| 2016 : AVALANCHE BIOTECHNOLOGIES 401(K) PLAN 2016 401k financial data |
|---|
| Transfers to/from the plan | 2016-12-31 | $0 |
| Total plan liabilities at end of year | 2016-12-31 | $0 |
| Total plan liabilities at beginning of year | 2016-12-31 | $0 |
| Total income from all sources | 2016-12-31 | $1,063,916 |
| Expenses. Total of all expenses incurred | 2016-12-31 | $241,850 |
| Benefits paid (including direct rollovers) | 2016-12-31 | $241,675 |
| Total plan assets at end of year | 2016-12-31 | $1,769,719 |
| Total plan assets at beginning of year | 2016-12-31 | $947,653 |
| Value of fidelity bond covering the plan | 2016-12-31 | $200,000 |
| Total contributions received or receivable from participants | 2016-12-31 | $558,668 |
| Expenses. Other expenses not covered elsewhere | 2016-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2016-12-31 | $23,971 |
| Other income received | 2016-12-31 | $136,985 |
| Noncash contributions received | 2016-12-31 | $0 |
| Net income (gross income less expenses) | 2016-12-31 | $822,066 |
| Net plan assets at end of year (total assets less liabilities) | 2016-12-31 | $1,769,719 |
| Net plan assets at beginning of year (total assets less liabilities) | 2016-12-31 | $947,653 |
| Assets. Value of participant loans | 2016-12-31 | $2,720 |
| Total contributions received or receivable from employer(s) | 2016-12-31 | $344,292 |
| Value of certain deemed distributions of participant loans | 2016-12-31 | $0 |
| Value of corrective distributions | 2016-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2016-12-31 | $175 |
